Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen and Femoston for Thin Endometrium in FET
NCT04292886Unknown
- Sponsor
- Nanjing University
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tamoxifen in thin endometrium, sponsored by Nanjing University. Primary endpoint: Endometrial thickness at 15 days. Status: unknown.
02
Drugs
tamoxifen
03
Conditions
thin endometrium
Beyond the preview
Go deeper on NCT04292886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292886.